E-ISSN: 2230-9861 | P-ISSN: 2349-1299 | Peer-Reviewed Journal (Refereed Journal) | Hybrid Open Access
Research and Reviews: A Journal of Pharmacology
Research & Reviews: A Journal of Pharmacology [2230-9861(e)]Â is a peer-reviewed hybrid open-access journal launched in 2011 and focused on the rapid publication of fundamental research papers on all areas of Pharmacology.
rrjop maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.
Dr. Laxmikant Borse, Principal
Sandip Institute of Pharmaceutical Sciences, Nashik, Maharashtra, India, 422213
Email :
Institutional Profile Link: https://sips.sandipfoundation.org/about-sips/principals-message/
Artificial intelligence (AI) is transforming clinical pharmacy practice by enhancing the safety, accuracy, and efficiency of medication management while supporting evidence-based clinical decision-making.
Systemic lupus erythematosus (SLE) is a prototypic, multi-systemic chronic inflammatory autoimmune disorder characterized by extreme clinical heterogeneity and the potential to involve virtually any organ or tissue.
Alzheimer's disease (AD) is a condition that leads to the deterioration of brain cells and is the primary cause of dementia, characterized by a decline in autonomy and cognitive function in day-to-day activities.
Digital Twin (DT) technology has emerged as a promising innovation in healthcare by creating dynamic virtual representations of physical systems through the integration of artificial intelligence (AI), computational modeling, real-time data, and advanced visualization technologies.
Cyclin-dependent kinase-2 (CDK-2) is an essential regulator in cell cycle progression and is an important therapeutic target in cancer drug development.
Cyclin-dependent kinase-2 (CDK-2) is an essential regulator in cell cycle progression and is an important therapeutic target in cancer drug development.
